Artificial Intelligence in The Pharmaceutical Industry: Applications, Challenges, And Future Landscape

Artificial intelligence (AI) is the simulation of human intelligence in machines that are designed to think and act like people. AI is sometimes defined as a technology that allows machines to imitate a range of complex human abilities. In 1956, Marvin Minsky and John McCarthy organised a meeting where the concept of artificial intelligence was first proposed ^[1][2]. The pharmaceutical business is undergoing a rapid transformation thanks to artificial intelligence (AI) and machine learning (ML), which are speeding up research, cutting costs, and increasing the effectiveness of numerous processes, from medication development to production.AI has greatly enhanced the diagnosis of illnesses. These days, developing sensible therapies and guaranteeing patients' wellbeing depend on disease analysis. AI is quickly entering the healthcare industry. In the biotech industry, AI is thought to play "a key supporting role in the fight to treat and stop" the virus and could "contribute to a solution coming faster than we would have otherwise." AI is acknowledged as playing a vital supporting role in the fight against and management of the virus, which could hasten the biotech industry's search for remedies.

Among the new projects utilising AI technology in pharmacy are drug discovery, drug delivery formulation, development, and other healthcare applications. Hype has already given way to hope in this movement. AI models are also used to predict in vivo reactions, the pharmacokinetic properties of the medicines, the right dosage, etc.^[3]AI technology is used to achieve both helpful interpretation and more accurate analyses ^[4]. According to this viewpoint, AI technology combines computer intelligence with a number of practical statistical models ^[5].  The worry of unemployment is frequently linked to the advancement and invention of AI technologies. However, the confidence that greatly helps to AI technology's effectiveness in the industry is the reason that practically all developments in its applications are being welcomed.

Classification of AI:

1.  Considering Functionality:

1. Narrow AI (Weak AI):

The majority of pharmaceutical applications use AI designed for certain tasks, such as patient data analysis, molecule screening, or drug target prediction.  As an illustration, consider IBM Watson for literature mining and Deep Chem for chemical property prediction.

2. General AI (Strong AI):

At this point, it is hypothetical that it will be able to reason, learn, and make decisions similarly to a human scientist.

Not yet used in pharmaceutical practice.

3. Super intelligent AI:
4. • Not yet practical; still speculative, surpassing human intellect.            • 

2) According to the Pharma Value Chain's Application Stage:

1. Drug Design and Discovery:

AI methods: reinforcement learning, generative adversarial networks (GANs), and deep learning.

• Applications:

• Identification and validation of targets (e.g., omics data analysis).    Predicting drug-target interactions.
• De novo design of molecules.
• Lead optimisation and compound screening.
• As an illustration, consider Benevolent AI, Atom-wise, Insilico Medicine.

2. Preclinical Development:

AI methods: such as toxicity prediction, QSAR models, and predictive modelling.

• Applications:

• Toxicity testing in silico.
• ADMET and pharmacokinetic forecasts.

• Simulating animal models to cut down on wet-lab experiments.

3. Clinical trials:

• AI methods: predictive analytics, pattern recognition, and natural language processing (NLP).

• Applications:

• Recruitment of patients (using EHR data).

• The choice and observation of trial sites.
• Adverse event detection in real time.

• Trial outcome prediction modelling.
• Trials.ai and Deep6AI are two examples.

4. Production and Supply Chain:

• AI methods: robotic process automation (RPA), machine learning, and analytics based on the Internet of Things.

• Applications:

• Quality control and process optimisation.
• Predictive equipment maintenance.
• Logistics management and supply chain forecasting.
• Pfizer, for instance, employs AI in production for predictive maintenance.

5. Post-Market surveillance and marketing:

• AI methods: Big data analytics, sentiment analysis, and natural language processing.
  • Applications:

• Patient and physician input.
• Pharmacovigilance is the analysis and detection of hazardous medication responses.
• Demand forecasting and targeted marketing.

2. Depending on the Technology Employed:

Table No 1: AI Types, Methods and Pharma application

Depending on the Domain or Stakeholder:

• R&D AI: Concentrated on design, development, and discovery.
• Clinical AI: centred on patient data and experiments.
• Commercial AI: Concentrated on consumer insight, marketing, and distribution.
• Regulatory AI: Facilitates audit trails, document analysis, and compliance

 Artificial Intelligence Frameworks [Machine learning Tools]:

• [ADVANCE TECHNIQUES] :

Figure No.4.1: AI in robotics and pharmacy

1. Robot pharmacy:

To improve patient safety, UCSF Medical Centre uses robotic technology to track and prepare drugs. They assert that 3,50,000 doses of medication have been expertly made by the technology. In terms of both size and medication administration accuracy, the robot has proven to be noticeably better than humans.^[6]

2. MEDI Robot:

MEDI stands for Medical and Engineering Designing Intelligence. AI tools The study that led to the creation of the pain management robot was managed by Tanya Beran, an Albertan professor of community health sciences at the University of Calgary. She got the concept from her experience working in hospitals where children scream throughout treatments. The robot tells the children what to anticipate during a medical procedure after building a rapport with them.^[7]

3. TUG robots:

Aethon TUG robots are designed to navigate hospitals independently and transport heavy objects like trash and linen as well as supplies, food, medications, and specimens. It is available in two configurations: permanent and secured carts and an interchange base platform that can be used to shift racks, bins, and carts.

4. The robot Erica:

The new care robot Erica was developed by Professor Hiroshi Ishiguro of Osaka University in Japan. It was developed in collaboration with the Japan Science and Technology Agency, Kyoto University, and the Advanced Telecommunications Research Institute International (ATR). It has a combination of Asian and European face traits. Additionally, it can speak Japanese. It wishes to go to Southeast Asia, see animated films, and have a life partner with whom it can converse like any other person.

AI FOR DRUG DISCOVERY:^[8]

Figure No.5.1: AI for drug discovery

AI has transformed drug discovery and research in a number of ways. The following are some of AI's most significant achievements in this field

• Target Identification:

To find possible therapeutic targets, AI systems can examine a variety of data types, including genomic, proteomic, and clinical data. AI helps develop drugs that can alter biological processes by identifying disease-associated targets and molecular pathways.

• Online Screening:

AI makes it possible to efficiently screen large chemical libraries in order to find therapeutic candidates that are highly likely to bind to a particular target. AI saves time and money by helping researchers prioritise and choose compounds for experimental testing by modelling chemical interactions and forecasting binding affinities.

• Structure-Activity Relationship (SAR) Modelling:

 AI models can create connections between a compound's chemical structure and its biological activity. By creating compounds with desired characteristics including high potency, selectivity, and advantageous pharmacokinetic profiles, researchers are able to optimise medication prospects.

• Designing Novel Drugs:

AI computers can suggest new chemical compounds that resemble drugs by using generative models and reinforcement learning. AI broadens the chemical universe and facilitates the creation of novel therapeutic candidates by learning from chemical libraries and experimental data.

• Optimisation of Drug Candidates:

AI algorithms are capable of analysing and optimising drug candidates by taking into account a number of variables, such as pharmacokinetics, safety, and efficacy. This aids scientists in optimising therapeutic compounds to increase their efficacy while reducing any adverse effects. 1) Drug Repurposing: AI methods can examine vast amounts of scientific data to find current medications that might be useful in treating various illnesses. AI speeds up and lowers the cost of drug research by repurposing current medications for new applications.

• Prediction of Toxicity:

By examining the properties and chemical structure of substances, AI systems are able to forecast the toxicity of drugs. Machine learning algorithms that have been trained on toxicological databases are able to recognise dangerous structural characteristics or predict negative outcomes. In clinical studies, this aids researchers in prioritising safer drugs and reducing possible negative reactions.^[9]

Pharma companies collaboration with AI Technology^[8]: Pharmaceutical businesses and AI have partnered to develop therapeutic items. A lot of the industry's AI partnerships are focused on clinical research and drug development.AI is essential to solving many of the most important problems facing the sector.The top ten pharmaceutical companies that use artificial intelligence (AI) or machine learning for drug discovery, clinical research, disease diagnosis, creative treatment, predictions, data analysis, and other purposes will be examined.

Figure No.6.1: Prominent pharmaceutical businesses and their relationships with AI firms involved in CNS illnesses, cardiovascular disease, and cancer.

Challenges Of AI In Pharma:        

Figure No.7.1: Challenges of AI in pharma

1. Related Data:

Challenge: This relates to data availability, quality, and security.

The quality of AI models depends on the quality of the training data. Pharma frequently works with fragmented data and old systems, which makes it challenging to get standardised, high-quality datasets. Additionally, patient data is extremely sensitive, making it difficult to comply with laws like GDPR and HIPAA on data security and privacy.

2. Adherence to Regulations:

Respecting current Good Manufacturing Practice (cGMP) and other legal requirements is a challenge. 

Specifics: Processes must be controllable, repeatable, and traceable, according to regulatory agencies like the FDA. These fundamental ideas are directly at odds with the "black box" character of many sophisticated AI/machine learning models, where the decision-making process is difficult to understand. To verify and guarantee the ongoing performance and non-drift of AI models, the industry needs frameworks.

3. Skilled Work:

Overcoming the lack of skilled workers is a challenge. Detail: A specialised workforce with a blend of data science, AI engineering, and pharmaceutical knowledge is necessary for the successful implementation of AI. The interdisciplinary skill set required to create, implement, and manage compliant AI systems in a highly regulated environment is in short supply worldwide.

4. Integration

Integrating AI into current systems in a seamless manner is a challenge.

Detail: Operational technology (OT) and IT systems that have been tested for decades are frequently used by pharmaceutical manufacturing. It is a difficult, expensive, and time-consuming technical and change management challenge to integrate these fragmented, inflexible legacy systems—like ERP or LIMS—with contemporary, cloud-native AI platforms without interfering with established processes.

5. Value Time:

The challenge is to ensure future proofing and quickly deploy AI technology.

Details: It can take a pharmaceutical company a very long time to go from a pilot AI project to a fully scaled, value-generating solution because of the complexity of validation, compliance, and integration. This sluggish pace puts the AI solution at danger of becoming antiquated (legacy costs) before it yields a substantial return on investment (ROI).

AI In Pharma Global Market:

Figure No.8.1: AI in Pharma Global Market Report 2025^[11]

The study outlines the anticipated expansion of AI in the pharmaceutical industry worldwide between 2024 and 2029.

Market Growth Rate: A compound annual growth rate (CAGR) of 25.20% is anticipated for the market.

Forecasts of Market Size (in USD billion):

 $2.92 billion in 2024

$3.78 billion in 2025

Estimated for 2029: $9.29 billion

Benefits of Artificial Intelligence Technology’s:

• The following are potential advantages of artificial intelligence technology:

1. Accuracy Improvement:

Artificial intelligence helps to improve accuracy by lowering errors and increasing precision. Because they can survive difficult air conditions, robust metallic robotic entities are used for space exploration.^[12]

2. Difficult Expedition:

Artificial intelligence shows promise in the mining sector and is being used in fuel exploration. By overcoming mistakes caused by humans, Al technology can explore the ocean.^[13] 1. Routine Implementations: Al contributes significantly to our daily activities and deeds. For example, GPS systems are frequently used on long trips, and the incorporation of artificial Android devices helps to anticipate user input and correct spelling mistakes.^[14]

3. Artificial intelligence Assistants:

To cut down on the requirement for human labour, smart organisations are using systems such as "avatars," or models of digital assistants. Because they are emotionless, the "avatar" is able to make the right, rational decisions. Human emotions and moods interfere with judgement efficiency, but computer intelligence can aid.^[15]

4. Clinical Applications:

Physicians can typically assess their patients' conditions and study any side effects or other health hazards associated with their prescriptions with the help of an Al software. Trainee surgeons can learn a lot by using Al apps, such as many artificial surgery simulators (such as those that model the heart, gastrointestinal tract, brain, etc.). ^[16]

5. Increase Technological Progress Rate:

Artificial intelligence (Al) technology is used in almost every cutting-edge technological development in the globe. It may produce a variety of computational modelling programs and aims to produce new compounds. Al technology is also used in the creation of medication delivery formulations.

6. Assistant and Relief:

All technology provides round-the-clock assistance to people of all ages, including children and the elderly, and serves as educational resources for teaching and learning. 

7. Infinite Possibilities:

Machines are emotionless and have no boundaries. These dispassionate computers are capable of doing a variety of jobs more accurately and efficiently than humans.^[18]

ADVANTAGES AND DISADVANTAGES OF AI:

Figure No 11.1: Advantages and Disadvantages of AI